Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile–associated diarrhea
Lukas Buendgens(Universitätsklinikum Aachen), Alexander Koch(RWTH Aachen University), Hanna Dückers(Universitätsklinikum Aachen), Michael T. Matthes(Universitätsklinikum Aachen), Jan Bruensing(Universitätsklinikum Aachen), Tom Luedde(Düsseldorf University Hospital), Frank Tacke(Charité - Universitätsmedizin Berlin), Christian Trautwein(TUM Klinikum)
Cited by 113
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
|Nature Reviews Gastroenterology & Hepatology|2011|1.4k